Research centre

Last updated on: 21/04/2015

1. Contact details{View data sources/studies associated with this centre}

Name of organisation

1) Department/Research groupUCL School of Pharmacy

2) Organisation/affiliationUCL School of Pharmacy, University College London

Short Name in the inventoryUCL School of Pharmacy

Website/Homepagehttp://www.ucl.ac.uk/pharmacy

Administrative Contact

Title Dr

Last name Wei

First name Li

Address line 1Mezzanine level, BMA House

Address line 2Tavistock Square

Address line 3

CityLondon

PostcodeWC1H 9JP

CountryUnited Kingdom

Phone number (incl. country code)4402078741275

Alternative phone number

Fax number (incl. country code)

Email address l.wei@ucl.ac.uk

Scientific Contact

Title Dr

Last name Wei

First name Li

Address line 1UCL School of Pharmacy

Address line 2Mezzanine level, BMA House

Address line 3Tavistock Square

CityLondon

PostcodeWC1H 9JP

CountryUnited Kingdom

Phone number (incl. country code)442078741275

Alternative phone number

Fax number (incl. country code)

Email address l.wei@ucl.ac.uk

Alternative Scientific Contact

Title Dr

Last name Murray

First name Macey

Address line 1Comprehensive Clinical Trials Unit at UCL

Address line 2Institute of Clinical Trials and Methodology

Address line 3Gower Street

CityLondon

PostcodeWC1E 6BT

CountryUnited Kingdom

Phone number (incl. country code)

Alternative phone number

Fax number (incl. country code)

Email address macey.murray@ucl.ac.uk

2. Description

The Centre for Paediatric Pharmacy Research (CPPR), established in April 2002, is a fruitful collaboration between UCL School of Pharmacy, the Institute of Child Health and Great Ormond Street Hospital for Children (GOSH). In addition, the specialist resources of universities and hospitals nationwide are utilised collaboratively to provide a focus for the training of health care professionals in the optimum use of medicines for children. Research conducted includes the development of age-appropriate formulations, aspects of clinical pharmacy, drug safety and pharmacoepidemiology, and pharmacogenetics. CPPR participates in four FP7-funded projects, one of which is the Global Research in Paediatrics Network (GRiP). Furthermore, CPPR was the UK coordinating Centre of the FP6-funded Taskforce in Europe for Drug Development in the Young (TEDDY). The Centre has been conducting paediatric pharmacoepidemiological studies since 2002, and will continue to focus research in this area.

3. Category

University based

4. Available resources

In houseVia Contacts/Network

Epidemiologist/Pharmacoepidemiologist Yes No

Statistician Yes No

Clinician No Yes

Clinical Pharmacologist No Yes

Pharmacist Yes No

Geneticist/Pharmacogeneticist No Yes

IT specialist Yes No

Ethics expertise No Yes

Regulatory expertise Yes Yes

9. Experience in secondary research and meta-analysis

Yes

10. Work with existing data resources in the past 3 years

Name of data resourceNo. of studies

CPRD11

IMS Disease Analyzer (IMS DA)8

THIN6

Vigibase3

11. Registries established by centre

None

12. Experience in collaboration in a study team

Collaborating Investigator

13. Current involvement in research networks

Other networks:

Network nameNationalInternationalLink to webpage

UK Medicines for Children Research Network (MCRN) Yes No http://www.mcrn.org.uk

Global Research in Paediatrics (GRiP) No Yes http://www.grip-network.org/

Improving Children's Antibiotic Prescribing (iCAP) Yes No

14. Interest in research opportunities which are funded

By pharmaceutical companies

By charities

By government

By research councils

By EU funding schemes

15. Interest in contract research only if free to publish results

Yes

16. Selected publications of the last 5 calendar years

ReferenceLink to web-publication

Murray ML, Hsia Y, Glaser K, Simonoff E, Murphy DG, Asherson PJ, Eklund H, Wong IC. Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care. Psychopharmacology (Berl) 2014;231(6):1011-1021 (epub 2013 May 17).

Rashed, A.N., Wong, I.C.K., Cranswick, N., Hefele, B., Tomlin, S., Jackman, J., Lee, K, Hon, K.L., Ong, J., Ghaleb, M., Chua, S.S., Hui, T.M., Rascher, W. and Neubert, A. (2011) Adverse Drug Reactions in Children - International Surveillance and Evaluation (ADVISE): A multicentre cohort study. Drug Saf., Jun 1; 35(6), pp. 481-94.

Sturkenboom MC, Verhamme KMC, Nicolosi A, Murray ML, Neubert A, Caudri D, Picelli G, Sen EF, Giaquinto C, Baiardi P, Felisi MG, Ceci A, Wong ICK, TEDDY European Network of Excellence. Drug use in children: cohort study in three European countries. British Medical Journal. 2008;337:a2245. doi: 10.1136/bmj.a2245

Neubert, A., Hsia, Y.F., de Jong-van den Berg, L.T., Janhsen, K., Glaeske, G., Furu, K., Kieler ,H., Nørgaard, M., Clavenna, A. and Wong I.C.K. (2011) Comparison of anti-diabetic drug prescribing in children and adolescents in seven European countries. Br J Clin Pharmacol, Dec; 72(6), pp. 969-977.

Murray ML, Insuk S, Banaschewski T, Neubert AC, McCarthy S, Buitelaar JK, Coghill D, Dittmann RW, Konrad K, Panei P, Rosenthal E, Sonuga-Barke EJ, Wong ICK. An inventory of European data sources for the long-term safety evaluation of methylphenidate. European Child and Adolescent Psychiatry 2013;22(10):605-618 (epub 2013 Mar 19).

Top